iCAD (ICAD) appoints Mark Koeniguer as CCO

Go back to iCAD (ICAD) appoints Mark Koeniguer as CCO

iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer

April 8, 2025 10:19 AM UTC

NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer cant hide by providing clinically proven AI-powered breast health solutions, today announced the appointment of Mark Koeniguer as Chief Commercial Officer (CCO), to lead the next phase of global growth for iCAD.

As CCO at iCAD, Koeniguer will assume responsibilities for revenue growth across North America and around the globe, bringing with him extensive executive experience in the medical imaging field... More